400 related articles for article (PubMed ID: 8886603)
21. Lauric acid as a model substrate for the simultaneous determination of cytochrome P450 2E1 and 4A in hepatic microsomes.
Clarke SE; Baldwin SJ; Bloomer JC; Ayrton AD; Sozio RS; Chenery RJ
Chem Res Toxicol; 1994; 7(6):836-42. PubMed ID: 7696540
[TBL] [Abstract][Full Text] [Related]
22. Involvement of cytochrome P450 3A enzyme family in the major metabolic pathways of toremifene in human liver microsomes.
Berthou F; Dreano Y; Belloc C; Kangas L; Gautier JC; Beaune P
Biochem Pharmacol; 1994 May; 47(10):1883-95. PubMed ID: 8204106
[TBL] [Abstract][Full Text] [Related]
23. Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes.
Yamazaki H; Inui Y; Yun CH; Guengerich FP; Shimada T
Carcinogenesis; 1992 Oct; 13(10):1789-94. PubMed ID: 1423839
[TBL] [Abstract][Full Text] [Related]
24. Nilutamide inhibits mephenytoin 4-hydroxylation in untreated male rats and in human liver microsomes.
Horsmans Y; Lannes D; Larrey D; Tinel M; Letteron P; Loeper J; Pessayre D
Xenobiotica; 1991 Dec; 21(12):1559-70. PubMed ID: 1785203
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of triacetyloleandomycin, alpha-naphthoflavone and diethyldithiocarbamate as selective chemical probes for inhibition of human cytochromes P450.
Chang TK; Gonzalez FJ; Waxman DJ
Arch Biochem Biophys; 1994 Jun; 311(2):437-42. PubMed ID: 8203907
[TBL] [Abstract][Full Text] [Related]
26. Oxidation of 1,2-epoxy-3-butene to 1,2:3,4-diepoxybutane by cDNA-expressed human cytochromes P450 2E1 and 3A4 and human, mouse and rat liver microsomes.
Seaton MJ; Follansbee MH; Bond JA
Carcinogenesis; 1995 Oct; 16(10):2287-93. PubMed ID: 7586124
[TBL] [Abstract][Full Text] [Related]
27. Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane.
Kharasch ED; Thummel KE
Anesthesiology; 1993 Oct; 79(4):795-807. PubMed ID: 8214760
[TBL] [Abstract][Full Text] [Related]
28. Diazepam metabolism by human liver microsomes is mediated by both S-mephenytoin hydroxylase and CYP3A isoforms.
Andersson T; Miners JO; Veronese ME; Birkett DJ
Br J Clin Pharmacol; 1994 Aug; 38(2):131-7. PubMed ID: 7981013
[TBL] [Abstract][Full Text] [Related]
29. In vitro inhibition of the cytochrome P450 (CYP450) system by the antiplatelet drug ticlopidine: potent effect on CYP2C19 and CYP2D6.
Ko JW; Desta Z; Soukhova NV; Tracy T; Flockhart DA
Br J Clin Pharmacol; 2000 Apr; 49(4):343-51. PubMed ID: 10759690
[TBL] [Abstract][Full Text] [Related]
30. Genetic polymorphism of human cytochrome P-450 (S)-mephenytoin 4-hydroxylase. Studies with human autoantibodies suggest a functionally altered cytochrome P-450 isozyme as cause of the genetic deficiency.
Meier UT; Meyer UA
Biochemistry; 1987 Dec; 26(25):8466-74. PubMed ID: 3442670
[TBL] [Abstract][Full Text] [Related]
31. Identification of the cytochrome P450 IIIA family as the enzymes involved in the N-demethylation of tamoxifen in human liver microsomes.
Jacolot F; Simon I; Dreano Y; Beaune P; Riche C; Berthou F
Biochem Pharmacol; 1991 Jun; 41(12):1911-9. PubMed ID: 2039544
[TBL] [Abstract][Full Text] [Related]
32. The role of S-mephenytoin 4'-hydroxylase in imipramine metabolism by human liver microsomes: a two-enzyme kinetic analysis of N-demethylation and 2-hydroxylation.
Chiba K; Saitoh A; Koyama E; Tani M; Hayashi M; Ishizaki T
Br J Clin Pharmacol; 1994 Mar; 37(3):237-42. PubMed ID: 8198931
[TBL] [Abstract][Full Text] [Related]
33. A convenient assay for mephenytoin 4-hydroxylase activity of human liver microsomal cytochrome P-450.
Shimada T; Shea JP; Guengerich FP
Anal Biochem; 1985 May; 147(1):174-9. PubMed ID: 4025815
[TBL] [Abstract][Full Text] [Related]
34. Caffeine metabolism by human hepatic cytochromes P450: contributions of 1A2, 2E1 and 3A isoforms.
Tassaneeyakul W; Birkett DJ; McManus ME; Tassaneeyakul W; Veronese ME; Andersson T; Tukey RH; Miners JO
Biochem Pharmacol; 1994 May; 47(10):1767-76. PubMed ID: 8204093
[TBL] [Abstract][Full Text] [Related]
35. Catalytic activities of human debrisoquine 4-hydroxylase cytochrome P450 (CYP2D6) expressed in yeast.
Ellis SW; Ching MS; Watson PF; Henderson CJ; Simula AP; Lennard MS; Tucker GT; Woods HF
Biochem Pharmacol; 1992 Aug; 44(4):617-20. PubMed ID: 1510710
[TBL] [Abstract][Full Text] [Related]
36. Coumarin-induced changes in delta-aminolaevulinic acid synthase and cytochrome P-450 in chick embryo liver.
Goeger DE; Anderson KE
Food Chem Toxicol; 1991 Mar; 29(3):145-51. PubMed ID: 2032655
[TBL] [Abstract][Full Text] [Related]
37. Evidence that CYP2C19 is the major (S)-mephenytoin 4'-hydroxylase in humans.
Goldstein JA; Faletto MB; Romkes-Sparks M; Sullivan T; Kitareewan S; Raucy JL; Lasker JM; Ghanayem BI
Biochemistry; 1994 Feb; 33(7):1743-52. PubMed ID: 8110777
[TBL] [Abstract][Full Text] [Related]
38. Identification of the major human hepatic cytochrome P450 involved in activation and N-dechloroethylation of ifosfamide.
Walker D; Flinois JP; Monkman SC; Beloc C; Boddy AV; Cholerton S; Daly AK; Lind MJ; Pearson AD; Beaune PH
Biochem Pharmacol; 1994 Mar; 47(7):1157-63. PubMed ID: 8161344
[TBL] [Abstract][Full Text] [Related]
39. Biotransformation of losartan to its active carboxylic acid metabolite in human liver microsomes. Role of cytochrome P4502C and 3A subfamily members.
Stearns RA; Chakravarty PK; Chen R; Chiu SH
Drug Metab Dispos; 1995 Feb; 23(2):207-15. PubMed ID: 7736913
[TBL] [Abstract][Full Text] [Related]
40. Caffeine as a probe for human cytochromes P450: validation using cDNA-expression, immunoinhibition and microsomal kinetic and inhibitor techniques.
Tassaneeyakul W; Mohamed Z; Birkett DJ; McManus ME; Veronese ME; Tukey RH; Quattrochi LC; Gonzalez FJ; Miners JO
Pharmacogenetics; 1992 Aug; 2(4):173-83. PubMed ID: 1306118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
